MAIN APPLICATION
Applications
HIGHLIGHTS
HA Concentration | 25 mg/ml |
Lidocaine | 0.3% |
Composition | Cross-linked HA |
Treated Areas & Indications | Filling of moderately pronounced wrinkles |
Injection Depth | Superficial to mid dermis |
Box | 2x1mL/Needle: 30G1⁄2 |
Estimated Duration | Protocol: 3 sessions every 3 weeks, twice a year |